Strategic Expansion CPC Scientific is actively expanding its American GMP manufacturing footprint with a localized US facility to strengthen global supply chain resilience, presenting opportunities for nearshored or regionalized peptide and oligonucleotide manufacturing partnerships.

Full Service Partner As a CRDMO offering end-to-end support from discovery to commercialization, CPC Scientific can be positioned as a one-stop partner for late-stage development, large-scale manufacturing, and regulatory services for IND, NDA, and BLA filings.

Regulatory Ready With strong FDA and ICH CGMP compliance and active regulatory support capabilities, there is a sales angle for clients needing expedited regulatory strategy, method development, validation, and regulatory documentation for new chemical entities.

Peptide and POC Focus Specialization in synthetic GMP peptides, oligonucleotides, and peptide-oligonucleotide conjugates positions CPC Scientific to pursue partnerships with biotech firms advancing peptide therapeutics, nucleic acid therapies, or targeted delivery platforms.

Industry Engagement Active participation in top industry events and sponsorships (BPS, BIO-Europe, TIDES Europe, RNA Leaders) signals thought leadership and networking opportunities to generate inbound leads and strategic collaborations.